Enanta Pharmaceuticals, Inc. (ENTA)
11.67
+0.26
(+2.28%)
USD |
NASDAQ |
Oct 20, 16:00
11.37
-0.30
(-2.57%)
After-Hours: 07:38
Enanta Pharmaceuticals Gross Profit (TTM) : 60.35M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 60.35M |
| March 31, 2026 | 64.28M |
| December 31, 2025 | 62.05M |
| September 30, 2025 | 60.74M |
| June 30, 2025 | 61.02M |
| March 31, 2025 | 61.30M |
| December 31, 2024 | 64.01M |
| September 30, 2024 | 65.30M |
| June 30, 2024 | 69.43M |
| March 31, 2024 | 70.30M |
| December 31, 2023 | 71.12M |
| September 30, 2023 | 76.83M |
| June 30, 2023 | 78.23M |
| March 31, 2023 | 78.75M |
| December 31, 2022 | 61.50M |
| September 30, 2022 | 38.42M |
| June 30, 2022 | 18.76M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Perspective Therapeutics, Inc. | -3.644M |
| Coherus Oncology, Inc. | 31.51M |
| BridgeBio Pharma, Inc. | 671.14M |
| RenovoRx, Inc. | 1.668M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |